Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. (3,5-dimethyl-4-(4'-hydoxy-3'-isopropylbenzyl)phenoxy)acetic Acid
2. Gc 1 Compound
3. Gc-1
4. Gc-1 Compound
5. Gc-1 Cpd
6. Qrx 431
7. Qrx-431
8. Qrx431
1. 211110-63-3
2. Gc-1
3. Qrx-431
4. Qrx 431
5. Chembl107400
6. Gc 1
7. Chebi:79988
8. 2-(4-(4-hydroxy-3-isopropylbenzyl)-3,5-dimethylphenoxy)acetic Acid
9. Xq31741e9q
10. 2-[4-[(4-hydroxy-3-propan-2-ylphenyl)methyl]-3,5-dimethylphenoxy]acetic Acid
11. Sobetirome (usan)
12. Sobetirome [usan]
13. {4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic Acid
14. Gc 1 Compound
15. Gc-1;qrx-431
16. [4-(4-hydroxy-3-isopropyl-benzyl)-3,5-dimethyl-phenoxy]-acetic Acid
17. 2-[4-[[4-hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]acetic Acid
18. Acetic Acid, 2-[4-[[4-hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]-
19. 3imy
20. B72
21. Sobetirome [inn]
22. Sobetirome [usan:inn]
23. Sobetirome [who-dd]
24. Schembl282119
25. Unii-xq31741e9q
26. Gtpl2639
27. Dtxsid60891557
28. Gc-1; Qrx-431
29. Bcp23779
30. Bdbm50115668
31. Zinc13475083
32. Akos024458221
33. Cs-0956
34. Db07425
35. Bs-42167
36. Hy-14823
37. Db-066428
38. Ft-0735243
39. A15241
40. D09381
41. A905652
42. Q27088838
43. Gc-1; Gc1; Gc 1; Qrx-431; Qrx 431; Qrx431
44. 3,5-dimethyl-4-(4''-hydroxy-3''-isopropylbenzyl)phenoxyacetic Acid
45. [4-(4-hydroxy-3-isopropyl-benzyl)-3,5-dimethyl-phenoxy]-acetic Acid(gc-1)
| Molecular Weight | 328.4 g/mol |
|---|---|
| Molecular Formula | C20H24O4 |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | 328.16745924 g/mol |
| Monoisotopic Mass | 328.16745924 g/mol |
| Topological Polar Surface Area | 66.8 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 396 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
92
PharmaCompass offers a list of Sobetirome API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sobetirome manufacturer or Sobetirome supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sobetirome manufacturer or Sobetirome supplier.
PharmaCompass also assists you with knowing the Sobetirome API Price utilized in the formulation of products. Sobetirome API Price is not always fixed or binding as the Sobetirome Price is obtained through a variety of data sources. The Sobetirome Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sobetirome manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sobetirome, including repackagers and relabelers. The FDA regulates Sobetirome manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sobetirome API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sobetirome supplier is an individual or a company that provides Sobetirome active pharmaceutical ingredient (API) or Sobetirome finished formulations upon request. The Sobetirome suppliers may include Sobetirome API manufacturers, exporters, distributors and traders.
Sobetirome Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sobetirome GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sobetirome GMP manufacturer or Sobetirome GMP API supplier for your needs.
A Sobetirome CoA (Certificate of Analysis) is a formal document that attests to Sobetirome's compliance with Sobetirome specifications and serves as a tool for batch-level quality control.
Sobetirome CoA mostly includes findings from lab analyses of a specific batch. For each Sobetirome CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sobetirome may be tested according to a variety of international standards, such as European Pharmacopoeia (Sobetirome EP), Sobetirome JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sobetirome USP).
